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Impact of Visceral Adiposity Measured by Abdominal Computed 
Tomography on Pulmonary Function
Although an inverse relationship between abdominal adiposity and pulmonary function 
has been suggested, direct measurement of abdominal adipose tissue has rarely been 
attempted. Our object is to determine the impact of abdominal adiposity on pulmonary 
function by directly measuring abdominal adipose tissue with abdominal computed 
tomography (CT). In this cross-sectional study, we included never-smokers between the 
ages of 18 and 85 yr, who had undergone spirometry and abdominal adipose tissue 
analysis with CT scans during November 1, 2005 to October 31, 2009 as part of the 
comprehensive health examination. Among a total of 3,469 participants, 890 (25.7%) 
were male. The mean body mass index and waist circumference among males and females 
were 24.6 kg/m
2 and 87.8 cm and 23.0 kg/m
2  and 83.0 cm, respectively. Although total 
adipose tissue (TAT) of the abdomen in males (269.1 cm
2) was similar to that in females 
(273.6 cm
2), the ratio of visceral adipose tissue (VAT)/subcutaneous adipose tissue (SAT) 
was different; 0.99 in males and 0.50 in females. In males, TAT, SAT, and VAT were 
inversely associated with the absolute value of forced vital capacity (FVC), and TAT and VAT 
were inversely associated with forced expiratory volume in one second (FEV1). However, in 
females, TAT and VAT, but not SAT, were inversely associated with absolute FVC and FEV1 
values. In conclusion, the amount of abdominal adipose tissue directly measured using CT 
is inversely associated with lung function. 
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Respiratory Diseases
INTRODUCTION
According to a 2008 World Health Organization report, more 
than 500 million adults globally were obese (1). Obesity is asso-
ciated with many health-related problems, such as cardiovas-
cular, metabolic, and respiratory system problems (2). Obesity, 
especially abdominal obesity, is suggested to be associated with 
decreased pulmonary function. Several researchers have report-
ed that abdominal obesity is inversely associated with forced 
expiratory volume in 1 cecond (FEV1) and forced vital capacity 
(FVC) (3). Because direct measuring of abdominal fat distribu-
tion is practically difficult, body mass index (BMI), waist circum-
ference (WC) (4, 5), waist/hip ratio (6) and abdominal height (3) 
have been used as surrogates for abdominal adiposity. However 
the association between these surrogates and pulmonary func-
tion has not been consistent among studies.
  Anatomically, abdominal adiposity is composed of two dif-
ferent compartments; visceral adipose tissue (VAT) and subcu-
taneous adipose tissue (SAT). VAT is metabolically more active 
and produces more pro-inflammatory adipokines than SAT (7). 
VAT is closely related to metabolic derangement, such as dys-
lipidemia (8), insulin resistance (9) and type 2 diabetes (7). Al-
though an inverse relationship between abdominal adiposity 
and pulmonary function has been suggested, it is unclear which 
compartment is more closely related with pulmonary function. 
Only a few studies with small numbers of participants have in-
vestigated the relationship between compartments of abdomi-
nal adiposity and pulmonary function. Magnetic resonance im-
aging (10) and dual-energy radiography absorptiometry (11) 
have been performed to directly measure fat distribution in re-
cent studies, but only a small number of subjects were enrolled.
  We attempted to identify the impact of abdominal adiposity 
on pulmonary function by directly measuring the amount of ab-
dominal adipose tissue using axial image post-processing from 
abdominal computed tomography (CT).
MATERIALS AND METHODS
Study population
In this cross-sectional study, we assessed study subjects between 
ages 18 to 85 yr who received comprehensive health examina-
tions during November 1, 2005 to October 31, 2009, which in-Park YS, et al.  •  Visceral Adiposity and Pulmonary Function
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cluded spirometry and abdominal adipose tissue analysis by 
CT scan. The examinations took place at the Healthcare System 
Gangnam Center (HCSGC) and Health Promotion/Disease Pre-
vention Center (HPDPC) of Seoul National University Hospital, 
Seoul, Republic of Korea. Among them, we included only never 
smokers and excluded subjects with history of malignant dis-
eases, self-reported asthma, and chronic lung diseases.
Measurements
Never-smokers were selected based on a self-administered med-
ical questionnaire. Anthropometric measurements such as blood 
pressure (BP), height, weight, and WC were retrieved from the 
database, and BMI was calculated as weight in kilograms divid-
ed by the square of the height in meters (kg/m
2). The population 
with BMI ≥ 23 kg/m
2 was considered as overweight (12). WC was 
measured at the WHO recommended site; the midpoint between 
the lower border of the rib cage and the iliac crest (13). Results 
of blood tests including fasting plasma glucose (FPG), serum 
lipids, serum insulin and high-sensitivity C-reactive protein (hs-
CRP) after overnight fasting were also collected. 
  Insulin resistance was assessed by the homeostatic model 
assessment of insulin resistance (HOMA-IR) (14). The formula 
for HOMA-IR is:
 
HOMA-IR= 
Fasting insulin (μU/mL) × Fasting glucose (mM/L)
                                                                                  22.5
  Low-density lipoprotein (LDL) cholesterol was measured di-
rectly. If directly measured LDL cholesterol was unavailable, 
LDL cholesterol was calculated (15). We excluded participants 
without directly measured LDL cholesterol level only when their 
triglycerides (TG) levels were above 400 mg/dL, since the esti-
mated LDL cholesterol is not valid when the TG level is above 
400 mg/dL. 
  Detailed methods of using abdominal CT cross-sectional im-
ages to measure abdominal adipose tissue area are described 
elsewhere (16). Briefly, subjects underwent 16-detector row CT 
imaging of the abdomen (Somatom Sensation 16, Siemens Med-
ical Solutions, Forchheim, Germany) in a supine position with 
both arms stretched above the head. A single slice at the umbi-
licus level was obtained. The adipose tissue area was determined 
using commercially available CT software (Rapidia 2.8; INFINITT, 
Seoul, Korea), and visceral and subcutaneous adipose tissue 
boundaries were defined using a manual tracing method with 
a cursor (Fig. 1). 
  Spirometric tests were performed following the American 
Thoracic Society recommendations (17) and were taken by ex-
perienced technicians. The same type of dry rolling seal spirom-
eter (Model 2130, Viasys Respiratory Care Inc., San Diego, CA, 
USA) was used in both centers. FVC, FEV1, and FEV1/FVC were 
measured, which were expressed both as absolute values (L) and 
predicted values (%), calculated from the formula based on Ko-
rean population (18).
Statistical analysis
We established multiple linear regression models to predict FVC 
and FEV1 from abdominal adiposity. Because the distribution of 
abdominal adipose tissue was significantly different for males 
and females, we calculated P value and adjusted R
2 values sep-
arately according to gender. Model 1 was adjusted for age and 
height. Model 2 was adjusted for the components of Model 1 and 
metabolic components such as weight, WC, systolic BP, HOMA-
IR, hs-CRP, and LDL cholesterol were added. Stata 10 (StataCorp, 
College Station, TX, USA) was used as the statistical software, 
and results were significant when P < 0.05. 
Ethics statement
The protocol was approved by the institutional review board of 
the Seoul National University Hospital (H-0909-016-294). The 
board waived informed consent from participants. The study 
Fig. 1. The measurement of abdominal adiposity using CT imaging of the abdomen. Visceral adipose tissue area (A) and total adipose tissue area (B) were measured using CT 
image of the abdomen at the umbilicus level.  
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was conducted in accordance with the Declaration of Helsinki.
RESULTS
Demographic and clinical characteristics of the 
participants
Of the 7,113 participants who underwent health examinations 
including spirometry and abdominal adipose tissue analysis 
during the study period, 3,469 met our inclusion criteria (Fig. 2). 
Of the 3,469 participants, 890 (25.7%) were male. The mean BMI 
and WC among males and females were 24.6 ± 2.8 kg/m
2 and 
87.8 ± 7.8 cm and 23.0 ± 3.0 kg/m
2 and 83.0 ± 8.3 cm, respective-
ly. The overweight population was 648 (72.8%) in male, and 1,210 
(46.9%) in female. Although TAT in males (269.1 ± 99.3 cm
2) was 
similar to that in females (273.6 ± 97.3 cm
2), the distribution of 
fat was different: the VAT/SAT ratio was 0.99 ± 0.38 in males and 
0.50 ± 0.23 in females. The predicted FVC and FEV1 were 88.4 ± 
11.2% and 113.8% ± 13.8% in males and 90.1% ± 11.4% and 111.5% 
± 14.0% in females. The average FEV1/FVC in males and females 
was 81.3% ± 6.7% and 82.4% ± 6.4%, respectively (Table 1). 
Association between abdominal fat and FVC
In males, TAT, SAT, and VAT were inversely associated with the 
absolute value of FVC, regardless of model. However, in females, 
SAT was not associated with FVC in either model 1 or 2. Instead, 
TAT and VAT in model 2, but not in model 1, were inversely as-
sociated with the absolute FVC value (Table 2).
Association between abdominal fat and FEV1
TAT, SAT, and VAT were also inversely associated with the abso-
lute value of FEV1 in model 1 in males. However, the inverse as-
sociation between SAT and FEV1 was attenuated in model 2 (P = 
Table 1. Baseline characteristics of the participants
Variables Male (n = 890) Female (n = 2,579)
Age (yr)     53.0 ± 10.6   53.4 ± 9.4
Height (cm) 169.2 ± 5.8 157.0 ± 5.3
Weight (kg)   70.5 ± 9.2   56.6 ± 7.7
BMI (kg/m
2)
   Underweight (BMI < 18.5)
   Normal range (BMI 18.5-22.9)
   Overweight (BMI ≥ 23)
  24.6 ± 2.8
  5 (0.6%)
237 (26.6%)
648 (72.8%)
  23.0 ± 3.0
 102 (4.0%)
1,267 (49.1%)
1,210 (46.9%)
Waist circumference (cm)   87.8 ± 7.8   83.0 ± 8.3
Blood pressure
   Systolic (mmHg)
   Diastolic (mmHg)
 
  123.7 ± 15.0
    79.6 ± 10.8
 
  118.2 ± 17.0
    73.0 ± 11.2
Fasting insulin (IU/mL)     8.7 ± 4.1     8.1 ± 3.7
Fasting glucose (mg/dL)     97.4 ± 19.0     92.1 ± 16.3
HbA1C (%)     5.9 ± 0.7     5.9 ± 0.6
HOMA-IR     2.1 ± 1.2     1.9 ± 1.0
Cholesterol (mg/dL)   191.8 ± 34.2   200.2 ± 35.2
TG (mg/dL)   117.1 ± 66.6     98.2 ± 53.1
HDL cholesterol (mg/dL)     50.1 ± 11.6     59.2 ± 14.0
LDL cholesterol (mg/dL)   121.2 ± 32.2   122.0 ± 31.9
hs-CRP (mg/dL)     0.14 ± 0.33     0.11 ± 0.29
Abdominal adiposity
   VAT (cm
2)
   SAT (cm
2)
   TAT (cm
2)
   VAT/SAT ratio
 
  131.2 ± 58.1
  137.9 ± 54.3
  269.1 ± 99.3
    0.99 ± 0.38
 
    90.1 ± 44.9
  183.5 ± 64.3
  273.6 ± 97.3
    0.50 ± 0.23
FVC
   Liter
   % predicted
 
    4.1 ± 0.7
    88.4 ± 11.2
 
    2.9 ± 0.5
    90.1 ± 11.4
FEV1
   Liter
   % predicted
 
    3.3 ± 0.6
  113.8 ± 13.8
 
    2.4 ± 0.4
  111.5 ± 14.0
FEV1/FVC (%)   81.3 ± 6.7   82.4 ± 6.4
Values are given as the mean ± SD. BMI, body mass index; HOMA-IR, homeostatic 
model assessment of insulin resistance; TG, triglyceride; HDL, high-density lipoprotein; 
LDL, low-density lipoprotein; hs-CRP, high-sensitivity C-reactive protein; VAT, visceral 
adipose tissue; SAT, subcutaneous adipose tissue; TAT, total adipose tissue; FVC, forced 
vital capacity; FEV1, forced expiratory volume in 1 second.
   No Spirometry (n = 62)
   Unknown smoking history (n = 216)
   Ex-smoker (n = 1,475)
   Current smoker (n = 1,137)
   Foreigner (n = 28)
   Missing data (n = 59)
   No Spirometry (n = 26)
   Unknown smoking history (n = 167)
   Ex-smoker (n = 259)
   Current smoker (n = 261)
   Foreigner (n = 5)
   Missing data (n = 10)
Fig. 2. Participants in this study. *Healthcare 
System Gangnam Center; 
†Health Promo-
tion/Disease Prevention Center. 
   HCSGC* 
   No. of participants with abdominal adipose tissue 
      analysis (N = 5,556)
   HPDPC
†
   No. of participants with abdominal adipose tissue 
      analysis (n = 1,557)
   Included No. of participants (n = 2,640) 
      (male 711, female 1,929)
   Total 3,469
   (male 890, female 2,579)
   Included No. of participants (n = 829) 
      (male 179, female 650)Park YS, et al.  •  Visceral Adiposity and Pulmonary Function
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0.056). In females, VAT in model 1 and TAT and VAT in model 2 
was inversely associated with FEV1, but there was no association 
between SAT and FEV1 in both model 1 and model 2 (Table 2).
Association between abdominal fat and predicted values 
of FVC and FEV1
Fig. 3 shows the scatter plots of predicted values of FVC and FEV1 
Table 2. Multiple linear regression models to predict forced vital capacity (FVC) and forced expiratory volume in 1 second (FEV1) from abdominal adipose tissue amount
Parameters
Male (n = 890) Female (n = 2,579)
Coefficients S.E. P value Adjusted R
2 Coefficients S.E. P value Adjusted R
2
FVC (L)
   Model 1*
      TAT (cm
2)
      SAT (cm
2)
      VAT (cm
2)
 
-0.00071
-0.00095
-0.00129
 
0.00016
0.00030
0.00028
 
< 0.001
0.002
< 0.001
0.477
0.471
0.478
 
0.00003
0.00019
-0.00030
 
0.00008
0.00011
0.00018
 
0.675
0.086
0.085
 
0.430
0.431
0.431
   Model 2
†
      TAT (cm
2)
      SAT (cm
2)
      VAT (cm
2)
 
-0.00177
-0.00142
-0.00166
 
0.00036
0.00054
0.00043
  
< 0.001
0.009
< 0.001
0.500
0.490
0.494
 
-0.00030
-0.00003
-0.00084
 
0.00014
0.00018
0.00025
0.036
0.875
0.001
0.442
0.441
0.444
FEV1 (L)
   Model 1*
      TAT (cm
2)
      SAT (cm
2)
      VAT (cm
2)
 
-0.00069
-0.00091
-0.00125
 
0.00014
0.00025
0.00023
 
< 0.001
< 0.001
< 0.001
0.541
0.535
0.543
-0.00010
-0.00006
-0.00037
0.00007
0.00010
0.00015
 
0.142
0.573
0.015
 
0.4767
0.476
0.477
   Model 2
†
      TAT (cm
2)
      SAT (cm
2)
      VAT (cm
2)
 
-0.00139
-0.00088
-0.00145
 
0.00030
0.00046
0.00037
 
< 0.001
0.056
< 0.001
 
0.553
0.544
0.550
 
-0.00040
-0.00025
-0.00072
 
0.00012
0.00016
0.00021
 
0.001
0.106
0.001
 
0.482
0.481
0.482
*Model 1 was adjusted for age and height; 
†Model 2 was adjusted for age, height, weight, waist circumference, systolic blood pressure, homeostatic model assessment of insulin 
resistance, high-sensitivity C-reactive protein and low-density lipoprotein cholesterol. TAT, total adipose tissue; SAT, subcutaneous adipose tissue; VAT, visceral adipose tissue.
Fig. 3. Scatter plot of predicted forced vital capacity (FVC % pred.) and predicted forced expiratory volume in 1 sec (FEV1 % pred.) according to the amount of visceral adipose 
tissue in overweight population (BMI > 23 kg/m
2). Both predicted FVC (%) (A, B) and FEV1 (%) (C, D) show negative correlation with the amount of visceral adipose tissue. 
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according to the amount of visceral adipose tissue in overweight 
population (BMI ≥ 23 kg/m
2). Both predicted FVC and FEV1 had 
statistically significant negative linear correlations with VAT. In 
normal BMI group (18.5 ≤ BMI < 23), only FVC showed nega-
tive linear correlation with VAT (P = 0.001 in male, P = 0.002 in 
female). 
Correlation between WC, BMI and the amount of adipose 
tissue measured by CT
Table 3 shows the adjusted R
2 between traditional abdominal 
adiposity indices and the amount of adipose tissue directly mea-
sured by abdomen CT. WC was best correlated with TAT (ad-
justed R
2 = 0.775, P < 0.001 in male, and adjusted R
2 = 0.701, P < 
0.001 in female). And the similar result was observed with BMI 
and TAT (adjusted R
2 = 0.672, P < 0.001 in male, and adjusted R
2 
= 0.649, P < 0.001 in female).
DISCUSSION
In our study, the amount of adipose tissue, TAT, SAT, or VAT, di-
rectly measured using abdominal CT was inversely associated 
with lung function among non-smokers, even after being ad-
justed for age, height, weight, WC, systolic BP, HOMA-IR, hs-
CRP, and LDL cholesterol. This observation implies that the 
amount of adipose tissue has a negative impact on pulmonary 
function even after adjustment for anthropometric and meta-
bolic parameters.
  How the amount of adipose tissue affects pulmonary function 
is still unclear. One possible explanation is that the systemic in-
flammation triggered by adipose tissue. Adipose tissue is asso-
ciated with elevated pro-inflammatory molecules, such as com-
plement C3, tumor necrosis factor-α, and interleukin (IL)-6 (7). 
In addition, activated macrophages in adipose tissue cause low-
grade chronic inflammation (19) and are associated with insu-
lin resistance (20, 21) in animal models. Furthermore, IL-6, pro-
duced mainly from VAT in individuals with obesity, is related to 
CRP level in arterial blood (22). An animal study has shown that 
IL-6 overexpression may cause an emphysematous lung phe-
notype (23). In epidemiologic studies, elevated CRP or IL-6 was 
associated with chronic inflammatory airway disease, such as 
asthma (24) or chronic obstructive pulmonary disorder (COPD) 
(25). According to a recently published observational study, sys-
temic inflammation was associated with reduced pulmonary 
function in never smoking male population (26). Considering 
these in vitro and in vivo observations, impaired pulmonary 
function among individuals with increased amount of adipose 
tissue could be understood in the context of systemic inflamma-
tion.
  Traditionally, BMI and WC have been used as indices of ab-
dominal adiposity. We directly compared the correlation be-
tween these surrogate indicators of abdominal adiposity and 
directly measured VAT, which is a metabolically active adipose 
tissue. In our study, WC and BMI were best correlated with TAT, 
and least correlated with VAT (Table 3). These phenomenon was 
also observed previously in Japanese population (27). In the con-
text of the consistent results, WC and BMI could well reflect the 
amount of TAT, but not VAT.
  Interestingly, the association between abdominal obesity and 
lung function was different in gender according to fat distribu-
tion. Compared between VAT and SAT, both were important in 
males, but only VAT was important in females (Table 2). In fact, 
there were several reports underscoring the importance of VAT 
as a metabolic risk among females rather than males. A cardio-
metabolic risk profile was associated with VAT more profound-
ly among females (28). In addition, the association between VAT 
and atherosclerosis was stronger in females than males (29). Our 
current study also coincided in the importance of VAT on pul-
monary function among females. However, the reasons for the 
more profound decreased pulmonary function of VAT among 
females remain to be discovered. 
  Strength of our study is that we included only never-smokers. 
Previous or current smoking is one of the most important con-
founding factors affecting impaired pulmonary function. To 
eliminate any influence of smoking, we excluded patients with 
even minimal history of smoking. Subsequently, inclusion of 
patients with COPD was minimized.
  However, to fully appreciate the results, we must consider the 
limitations of this study. First, the study participants were not 
representative of the general population. Participants in our 
study were those individuals who had undergone medical ex-
aminations consisting of rather expensive tests. These subjects 
might be more concerned about their health and could afford 
to pay the cost of the program. Therefore, a relatively healthier 
and wealthier group compared to the general population was 
included in this study. Second, because this was a cross-section-
al study, we could not infer a cause and effect relationship be-
tween abdominal obesity and decreased lung function. To con-
firm the causality of abdominal obesity on pulmonary function, 
an individualized follow up study is needed.
  In conclusion, the amount of abdominal adipose tissue direct-
ly measured using CT is inversely associated with lung function. 
However, the amount of TAT is more important for pulmonary 
function in males, but the amount of VAT rather than SAT is more 
Table 3. The results of adjusted R
2 in linear regression between WC, BMI and the 
amount of adipose tissue measured by CT
Male Female
TAT SAT VAT TAT SAT VAT
WC 0.775 0.659 0.558 0.701 0.594 0.504
BMI 0.672 0.659 0.558 0.649 0.550 0.468
All the values were P < 0.001. WC, waist circumference; BMI, body mass index (kg/
m
2); TAT, total adipose tissue; SAT, subcutaneous adipose tissue; VAT, visceral adipose 
tissue.Park YS, et al.  •  Visceral Adiposity and Pulmonary Function
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important in females.
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Impact of Visceral Adiposity Measured by Abdominal Computed Tomography on 
Pulmonary Function
Young Sik Park, Hyuk Tae Kwon, Seung-Sik Hwang, Seung Ho Choi, Young Min Cho, Jinwoo Lee and Jae-Joon Yim 
Although an inverse relationship between abdominal adiposity and pulmonary function has been suggested, direct measurements 
of abdominal adipose tissue have been attempted only rarely. Through cross-sectional study analyzing 3,469 never-smokers, we 
confirmed that the amount of abdominal adipose tissue directly measured using CT was inversely associated with lung function, 
and this tendency showed gender-difference. The amount of total adipose tissue is more important for pulmonary function in 
males, but the amount of visceral adipose tissue rather than subcutaneous adipose tissue is more important in females.